Search Results - "Nahleh, Z. A."

A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy by Elimimian, E B, Elson, L, Stone, E, Butler, R S, Doll, M, Roshon, S, Kondaki, C, Padgett, A, Nahleh, Z A

“…Art therapy may improve the physical, mental, and emotional wellbeing of individuals for a variety of purposes. It remains understudied and underutilized in…”
Get full text

Correction to: A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy by Elimimian, E. B, Elson, L, Stone, E, Butler, R. S, Doll, M, Roshon, S, Kondaki, C, Padgett, A, Nahleh, Z. A

“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer by Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Sikov, W. M., Perez, E. A., Chennuru, S., Mirshahidi, H. R., Corso, S. W., Lew, D. L., Pusztai, L., Livingston, R. B., Hortobagyi, G. N.

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

Symptom management needs of oncology outpatients by Whitmer, Kyra M, Pruemer, Jane M, Nahleh, Zeina A, Jazieh, Abdul R

“…What were the needs of outpatients for symptom management? A multidisciplinary team assembled to determine the need for a symptom management clinic. Two…”
Get more information

SWOG S0800 rates in inflammatory or locally advanced breast cancer by Nahleh, Z. A, Barlow, W. E, Hayes, D. F, Schott, A. F, Gralow, J. R, Sikov, W. M, Perez, E. A, Chennuru, S, Mirshahidi, H. R, Corso, S. W, Lew, D. L, Pusztai, L, Livingston, R. B, Hortobagyi, G. N

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

SWOG S0800 by Pusztai, L, Hayes, D. F, Hortobagyi, G. N, Perez, E. A, Chennuru, S, Corso, S. W, Livingston, R. B, Gralow, J. R, Mirshahidi, H. R, Schott, A. F, Nahleh, Z. A, Lew, D. L, Sikov, W. M, Barlow, W. E

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

Phase II trial of biweekly gemcitabine, paclitaxel, and bevacizumab as frontline therapy for metastatic breast cancer (MBC) by Nahleh, Z. A., Gupta, R., Abrams, J., Gartner, E. M., Reichle, L.

“…Abstract only…”
Get full text

Sudden onset fatigue (SOF) in patients with breast cancer: Characteristics and symptomatology by Nahleh, Z. A., Wu, H., Galvin, E., Leedy, D.

“…Abstract only e20637 Background: Cancer-related fatigue is underrecognized and poorly managed. Unpredictability and rapid onset in fatigue is stressed by…”
Get full text

Outcome of patients with nonmetastatic breast cancer receiving nitrogen-containing bisphosphonates: A comparative analysis from the Metropolitan Detroit Cancer Surveillance System (MDCSS) by Nahleh, Z. A., Abrams, J., Bhargava, A., Nirmal, K., Graff, J. J.

“…Abstract only…”
Get full text

Molecular markers for epithelial-mesenchymal transition (EMT) and tumor aggressiveness in breast carcinoma by Sethi, S., Sarkar, F. H., Ahmed, Q., Bandyopadhyay, S., Nahleh, Z. A., Sakr, W., Munkarah, A., Ali-Fehmi, R.

“…Abstract only…”
Get full text

The concordance of estrogen and progesterone receptor status (ER-PR) and HER2/neu expression in DCIS coexistent with micro-invasive and invasive carcinoma by Ali-Fehmi, R., Nahleh, Z. A., Ahmed, Q., Sethi, S., Sakr, W., Hussein, Y., Ibrahim, M., Albashiti, B., Hayek, K., Bandyopadhyay, S.

“…Abstract only…”
Get full text

Treatment of unresectable or metastatic pancreatic cancer in the VA population: Does it improve survival? by Mekan, S. F., Komrokji, R. S., Beg, M. S., Nahleh, Z. A., Safa, M. M.

“…Abstract only 15121 Background: Locally advanced and metastatic pancreatic adenocarcinoma present as a treatment challenge because of poor outcomes with…”
Get full text

Hormonal therapy for male breast cancer: A different approach for a different disease by Nahleh, Zeina A.

“…Male breast cancer (MBC) is on the rise in the United States [Surveillance, Epidemiology, and End Results (SEER) Program ( www.seer.cancer.gov) SEER Stat…”
Get full text

Abstract P3-07-06: BRCA mutations among Hispanic breast cancer patients of Mexican origin in El Paso, TX by Nahleh, ZA, Heydarian, R, Saldivar, JS, Castaneda, K, Sanchez, L

“…Introduction: El Paso, TX is a large American-Mexican border city of population around 900,000, 85% Hispanic of Mexican origin. Limited cancer research has…”
Get full text

Is hyperglycemia a prognostic factor in pancreatic cancer? by Mekan, S. F., Safa, M. M., Komrokji, R. S., Nahleh, Z. A., Jazieh, A. R.

“…Abstract only 14078 Background: Pancreatic hyperglycemia is one of the manifestations of pancreatic cancer.The purpose of this study is to explore the…”
Get full text

Improvement of survival in VA patients with gall bladder cancer given chemotherapy by Atiq, M., Safa, M. M., Komrokji, R. S., Jazieh, A. R., Muhleman, A. F., Nahleh, Z. A., Pancoast, J.

“…Abstract only 4132 Background: Gallbladder carcinoma, though rare, has very poor prognosis. Most of patients with gall bladder carcinoma present with either…”
Get full text

Hodgkin’s lymphoma among veterans: Does race matter? by Komrokji, R. S., Mekan, S. F., Safa, M. M., Nahleh, Z. A., Pancoast, J. R., Muhleman, A. F., Jazieh, A. R.

“…Abstract only 17538 Background: Racial disparities in Hodgkin’s lymphoma (HL) are not well studied. Earlier studies suggested that black patients received less…”
Get full text

Hodgkin’s lymphoma in the elderly veterans: We need to do better by Al Sayyed, M. H., Maken, S. F., Safa, M. M., Nahleh, Z. A., Pancoast, J. R., Muhleman, A. F., Jazieh, A. R., Komrokji, R. S.

“…Abstract only 17554 Background: Recent studies demonstrated worse outcome in elderly patients diagnosed with Hodgkin’s Lymphoma (HL). The purpose of this study…”
Get full text

Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer by Nahleh, Zeina A, Jazieh, Abdul-Rahman

Get full text